Skip to main content

Month: August 2022

Acceleration of revenue growth in the 2nd quarter: +36.2% (+8.1% at constant scope)

    PRESS RELEASE  25/08/2022 Acceleration of revenue growth in the 2nd quarter: +36.2% (+8.1% at constant scope) Revenue in the 1st half-year up by 32.8% (+3.7% at constant scope) Annual objectives confirmed Satisfactory revenue for the 1st half-year, in line with expectations LACROIX’s revenue in the 2nd quarter amounted to €173.2 million – an increase of 36.2% compared with the 2nd quarter of 2021, and an acceleration in growth compared with the 1st quarter of 2022 (+29.4%). At constant scope, LACROIX recorded a growth in revenue of 8.1%. This growth is mainly due to the continuation of good market momentum for the Environment Activity and Electronics Activity, and the impact of passing on the increase in procurement costs for certain components in selling prices. In line with expectations, LACROIX recorded...

Continue reading

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2022

Disclosure of Share Capital and Voting Rights Outstanding as of July 31, 2022 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers) Charenton-le-Pont, France (August 25, 2022 – 6:00 pm) – As of July 31, 2022, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down as indicated below.  July 31, 2022Shares outstanding           447,420,4191Number of real voting rights (excluding treasury shares) 443,676,730Theoretical number of voting rights (including treasury shares) 447,420,419It is to be noted that voting rights are capped at 31%, applicable to any shareholder, in accordance with a formula contained...

Continue reading

Andes Technology USA Corp. to Host First Virtual Career Event Seeking RISC-V Talent to Grow Its North America Operation

SAN JOSE, Aug. 25, 2022 (GLOBE NEWSWIRE) — Andes Technology USA Corporation, the headquarters of North America operations of Hsinchu, Taiwan-based Andes Technology Corporation, a leading supplier of high efficiency, low-power 32/64-bit RISC-V processor cores and Founding Premier member of RISC-V International, today announced its first Virtual Career Event to grow it R&D facilities in North America. With a significant headcount growth of over 350% in the past year, Andes Technology USA continues to expand its North American presence. The company is hiring engineers to work remotely as well as in its three west coast North America offices. Andes will host its first Virtual Career Event on September 8th.  All levels of engineers with an interest in CPU, microarchitecture, RTL, or pre-silicon verification are encouraged to attend. As...

Continue reading

Egide: Appointment of Terry TOH as the new manager of the Cambridge facility (Maryland, USA).

Bollène, August 25, 2022 – 06 :00 pm (CET)Press Release Appointment of Terry TOH as the new manager of the Cambridge facility (Maryland, USA). The Egide Group (Euronext Paris™- Compartment C – ISIN: FR0000072373) announces the appointment of Terry TOH as manager of the Cambridge facility. He succeeds Kirk WILLIAMSON, who has decided to pursue his career outside the Group. This appointment is effective as of June 1, 2022. Jim COLLINS, President and CEO of Egide Group, comments, “We are proud to announce the appointment of Terry TOH as the General Manager of the Cambridge facility. Terry comes to Egide with vast management experience in a manufacturing environment and has experience in marketing, sales, business development and engineering. We are fortunate to have someone with Terry’s experience to lead the Cambridge facility...

Continue reading

First Wave BioPharma, Inc. Announces Reverse Stock Split

BOCA RATON, Fla., Aug. 25, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc. (NASDAQ:FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal diseases, today announced that it intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 30 pre-split shares. First Wave’s common stock will continue to be traded on the NASDAQ Capital Market under the symbol FWBI and will begin trading on a split-adjusted basis when the market opens on Friday, August 26, 2022, under a new CUSIP number, 33749P200. At the effective time of the reverse stock split, every thirty shares of First Wave’s issued and outstanding common stock will be converted automatically into one issued and...

Continue reading

Nuvei Releases Inaugural Environmental, Social and Governance Report

Report highlights initiative to deliver long-term sustainable value for all stakeholders MONTREAL, Aug. 25, 2022 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), tomorrow’s payment platform, announces the publication of its inaugural Environmental, Social, and Governance (“ESG”) report. The report sets out Nuvei’s ongoing drive to build sustainable business practices to protect the environment, support the communities in which it operates and create value for employees, investors, and customers. “Nuvei’s value creation story is simple: we only grow when our stakeholders thrive,” said Nuvei Chair and CEO Philip Fayer. “So, whether it is helping our customers accelerate their business, fostering an engaged and diverse workforce, supporting our local communities or achieving superior financial...

Continue reading

Deutsche Balaton Aktiengesellschaft Announces Filing of Early Warning Report

HEIDELBERG, Germany, Aug. 25, 2022 (GLOBE NEWSWIRE) — Deutsche Balaton Aktiengesellschaft (“Deutsche Balaton”) and its Joint Actors acquired 5,267,539 Common Shares (“Shares”) of Elemental Royalties Corp. (“ELEMENTAL”) (TSX-V: ELE) in exchange for shares of Altus Strategies plc (“ALTUS”), representing 3.56% of the issued and outstanding Shares, by way of a scheme of arrangement pursuant to Part 26 of the Companies Act 2006 under the laws of the United Kingdom in exchange for common shares in the capital of ELEMENTAL (the “Merger”) pursuant to a cooperation agreement between ELEMENTAL and ALTUS dated June 14, 2022, as amended and restated June 21, 2022. Immediately prior to the completion of the Merger, Deutsche Balaton and its Joint Actors held 8,400,000 Shares, representing 10.73% of the issued and outstanding Shares prior to...

Continue reading

Nasdaq Halts Smart Powerr Corp.

NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Smart Powerr Corp. (Nasdaq: CREG) at 11:07:03 A.M. Eastern Time for “additional information requested” from the company at a last sale price of $3.5762. Trading will remain halted until Smart Powerr Corp. has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq Media Contact: Sophia Weisssophia.weiss@nasdaq.com  NDAQO

Continue reading

Nasdaq Halts Statera Biopharma, Inc.

NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) — The Nasdaq Stock Market® (Nasdaq: NDAQ) announced that trading was halted today in Statera Biopharma, Inc. (Nasdaq: STAB) at 11:01:52 A.M. Eastern Time for “additional information requested” from the company at a last sale price of $0.215. Trading will remain halted until Statera Biopharma, Inc. has fully satisfied Nasdaq’s request for additional information. For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq Media Contact: Sophia Weisssophia.weiss@nasdaq.com NDAQO  

Continue reading

RAMSAY SANTE : Provisional annual Results at the end of June 2022

PRESS RELEASE Paris, August 25, 2022 Provisional annual results at end June 2022 The solid performance of the Nordic countries has led to an improvement in the results of the Ramsay Santé group, despite the persistent challenges of high inflation, a shortage of nursing and clinical staff and the ongoing pandemic, in which Ramsay Santé has continued to play a leading role in Europe. In line with its Yes We Care 2025 strategic plan, Ramsay Santé has continued to invest at a level comparable with previous years in order to consolidate its position with patients as a comprehensive and integrated healthcare player in continental Europe.With more than 10,000 COVID patients treated in France, including 4,500 in critical care, Ramsay Santé has maintained its commitment to combating COVID over the past 12 months. In Sweden, we have continued...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.